Cyclarity Therapeutics

Novato, CA · Founded 2019 · Privately Held (backing)

Developer of compound-based drugs designed to treat the underlying causes of age-related diseases. Cyclarity Therapeutics is based in Novato, CA and was founded in 2019. It was valued at $34.3 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $34 million across 1 recorded round; the latest was a $10.3 million early-stage round in Dec 2024.

PMV mark · valuation
$34.3M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$34.0M
Last round
Early Stage VC
Dec 2024
What is Cyclarity Therapeutics worth?
$34.3MPrivateMarketView mark · Oct 2026

Valued at $34.3M at its later-stage round, Dec 2024. Nothing has traded since.

Private Market View
More of Cyclarity Therapeutics with a free Private Market View account
  • ·The complete investor list: 12 names
  • ·Watch Cyclarity Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 38 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free Private Market View account.Unlock the axis

Membership and data by Private Market View

Cyclarity Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$10.3M▮
Unlock post-money valuations

Membership and data by Private Market View

Cyclarity Therapeutics valuation

Cyclarity Therapeutics was valued at $34.3 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Cyclarity Therapeutics raised?

Cyclarity Therapeutics has raised $34 million in total; 1 of its rounds is on record. The largest on record was a $10.3 million early-stage round in Dec 2024.

Cyclarity Therapeutics has filed 1 Form D with the SEC, most recently in Dec 2024 ($10.3 million sold to 19 investors).

How Cyclarity Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cyclarity Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Cyclarity Therapeutics

What is Cyclarity Therapeutics worth?
Cyclarity Therapeutics is valued at $34.3M as of Oct 2026. Valued at $34.3M at its later-stage round, Dec 2024. Nothing has traded since.
How much has Cyclarity Therapeutics raised?
Cyclarity Therapeutics has raised $34.0M in total funding across 1 recorded rounds.
When did Cyclarity Therapeutics last raise?
Cyclarity Therapeutics last raised in Dec 2024 (Early Stage VC), raising $10.3M.